Table 3 Suboptimal non HDLC concentrations in relation to socio-demographic and clinical characteristics at bivariable analysis
From: Dyslipidaemia in a Black African diabetic population: burden, pattern and predictors
Characteristic | Non HDLC ≥ 3.4 mmol/l | Non HDLC < 3.4 mmol/l | OR 95% CI | p value |
|---|---|---|---|---|
Age, median (IQR) | 56 (48–67) | 53 (43–61) | 1.02 (1.01–1.04) | 0.001 |
Gender | ||||
Male | 65 (47.10) | 73 (52.90) | 1 | <0.005 |
Female | 181 (65.82) | 94 (34.18) | 2.16 (1.43–3.28) | |
Type of hospital | ||||
Government | 126 (63.32) | 73 (36.68) | 1 | 0.134 |
Private | 120 (56.07) | 94 (43.93) | 0.74 (0.50–1.10) | |
Place of residence | ||||
Rural | 85 (63.43) | 49 (36.57) | 1 | 0.267 |
Urban | 161 (57.71) | 118 (42.29) | 0.79 (0.51–1.20) | |
Smoking | ||||
Smoker | 6 (66.67) | 3 (33.33) | 1 | 0.662 |
Non smoker | 240 (59.41) | 167 (40.44) | 0.73 (0.18–2.97) | |
Occupation | ||||
Employed | 122 (59.22) | 84 (40.78) | 1 | 0.888 |
Unemployed | 124 (59.90) | 83 (40.10) | 1.03 (0.69–1.52) | |
Co-existing HT | ||||
Yes | 179 (63.25) | 104 (36.75) | 1 | 0.025 |
No | 67 (51.54) | 63 (48.46) | 0.62 (0.41–0.94) | |
DM type | ||||
Type 1 DM | 16 (29.09) | 39 (70.91) | 1 | <0.005 |
Type 2 DM | 227 (64.31) | 126 (35.69) | 4.39 (2.36–8.17) | |
Family history of DM | ||||
Yes | 162 (63.04) | 95 (36.96) | 1 | 0.066 |
No | 84 (53.85) | 72 (46.15) | 0.68 (0.46–1.02) | |
HIV co-morbidity | ||||
Yes | 9 (52.94) | 8 (47.06) | 1 | 0.571 |
No | 237 (59.85) | 159 (40.15) | 1.32 (0.50–3.51) | |
Median age at diagnosis | 53 (48–58) | 46 (37–55) | 1.03 (1.01–1.04) | 0.001 |
Median (IQR) years duration with DM. | 6 (1–15) | 4 (2–10) | 1.02 (0.99–1.05) | 0.265 |
BMI in kg/m 2 median (IQR) | 28.7 (25–34.3) | 27 (23–30.6) | 1.07 (1.03–1.11) | <0.005 |
BP in mmHg, median (IQR) | ||||
SBP | 130 (120–150) | 139 (124–156) | 1.01 (1.00–1.02) | 0.020 |
DBP | 70 (70–78) | 80 (74–91) | 1.02 (1.01–1.03) | 0.008 |
HbA1c (%) | 9.2 (6.8–10.1) | 9 (6.85–12.4) | 1.00 (0.95–1.05) | 0.967 |
Drugs | ||||
I nsulin therapy | 94 (52.22) | 86 (47.78) | 1 | 0.005 |
On OHA | 149 (65.93) | 77 (34.07) | 1.77 (1.18–2.65) | |
On statin therapy n (%) | ||||
Yes | 184 (56.44) | 142 (43.56) | 1 | 0.013 |
No | 62 (71.26) | 25 (28.74) | 0.52 (0.31–0.87) | |